120 related articles for article (PubMed ID: 17409260)
1. Renal responses to the kappa-opioid-receptor agonist U-50488H in conscious lambs.
Qi W; Ebenezar KK; Samhan MA; Smith FG
Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R162-8. PubMed ID: 17409260
[TBL] [Abstract][Full Text] [Related]
2. Modulation of systemic and renal haemodynamics by kappa-opioids in conscious lambs.
Qi W; Smith FG
Exp Physiol; 2006 Sep; 91(5):877-85. PubMed ID: 16728455
[TBL] [Abstract][Full Text] [Related]
3. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
Kapusta DR; Obih JC
J Pharmacol Exp Ther; 1993 Oct; 267(1):197-204. PubMed ID: 8229746
[TBL] [Abstract][Full Text] [Related]
4. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR
J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735
[TBL] [Abstract][Full Text] [Related]
5. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
6. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.
Ko MC; Willmont KJ; Lee H; Flory GS; Woods JH
Brain Res; 2003 Aug; 982(1):38-44. PubMed ID: 12915238
[TBL] [Abstract][Full Text] [Related]
7. Sigma-1 receptor function is critical for both the discriminative stimulus and aversive effects of the kappa-opioid receptor agonist U-50488H.
Mori T; Yoshizawa K; Nomura M; Isotani K; Torigoe K; Tsukiyama Y; Narita M; Suzuki T
Addict Biol; 2012 Jul; 17(4):717-24. PubMed ID: 21392175
[TBL] [Abstract][Full Text] [Related]
8. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN
J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
[TBL] [Abstract][Full Text] [Related]
9. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
Jewett DC; Grace MK; Jones RM; Billington CJ; Portoghese PS; Levine AS
Brain Res; 2001 Aug; 909(1-2):75-80. PubMed ID: 11478923
[TBL] [Abstract][Full Text] [Related]
10. Vagotonic effects of enkephalin are not mediated by sympatholytic mechanisms.
Barlow MA; Deo S; Johnson S; Caffrey JL
Exp Biol Med (Maywood); 2006 Apr; 231(4):387-95. PubMed ID: 16565434
[TBL] [Abstract][Full Text] [Related]
11. Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.
Kapusta DR; Jones SY; DiBona GF
J Pharmacol Exp Ther; 1989 Oct; 251(1):230-7. PubMed ID: 2552076
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of urinary bladder motility by a spinal action of U-50488H in rats.
Gotoh A; Goto K; Sengoku A; Shirakawa T; Akao Y; Fujisawa M; Okada H; Arakawa S; Sasaki H; Kamidono S
J Pharm Pharmacol; 2002 Dec; 54(12):1645-50. PubMed ID: 12542894
[TBL] [Abstract][Full Text] [Related]
13. Kappa opioids modulate the arterial baroreflex control of heart rate in conscious young sheep.
Qi W; Smith FG
Can J Physiol Pharmacol; 2007 Aug; 85(8):811-7. PubMed ID: 17901891
[TBL] [Abstract][Full Text] [Related]
14. Effects of rat brain kappa 1- and kappa 2-opioid receptors after chronic treatment with non-peptide kappa-agonists.
McConnaughey MM; Zhai QZ; Ingenito AJ
J Pharm Pharmacol; 1998 Oct; 50(10):1121-5. PubMed ID: 9821658
[TBL] [Abstract][Full Text] [Related]
15. Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria.
Raffa RB; Baron DA; Tallarida RJ
Eur J Pharmacol; 2006 Jul; 540(1-3):200-1. PubMed ID: 16737694
[TBL] [Abstract][Full Text] [Related]
16. U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice.
Hiramatsu M; Hyodo T; Kameyama T
Eur J Pharmacol; 1996 Nov; 315(2):119-25. PubMed ID: 8960874
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.
Gray AC; White PJ; Coupar IM
Br J Pharmacol; 2005 Mar; 144(5):687-94. PubMed ID: 15678085
[TBL] [Abstract][Full Text] [Related]
18. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
Wettstein JG; Grouhel A
Pharmacol Biochem Behav; 1996 Feb; 53(2):411-6. PubMed ID: 8808151
[TBL] [Abstract][Full Text] [Related]
19. Inducible HSP70 mediates delayed cardioprotection via U-50488H pretreatment in rat ventricular myocytes.
Zhou JJ; Pei JM; Wang GY; Wu S; Wang WP; Cho CH; Wong TM
Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H40-7. PubMed ID: 11406466
[TBL] [Abstract][Full Text] [Related]
20. Acidosis antagonizes intracellular calcium response to kappa-opioid receptor stimulation in the rat heart.
Pei JM; Yu XC; Bian JS; Wong TM
Am J Physiol; 1999 Sep; 277(3):C492-500. PubMed ID: 10484336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
